7 withdrawn. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Withdrawn 7 |
Follow Chronic Obstructive Pulmonary Disease: new trials by email Literature Review of Chronic Obstructive Pulmonary Disease trials Research Report on Chronic Obstructive Pulmonary Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TOBacco STOP in Chronic Obstructive Pulmonary Disease-Trial - Study Protocol High-intensity smoking cessation intervention, Low-intensity smoking cessation intervention - Chronic Obstructive Pulmonary Disease, Smoking Cessation | Phase 4 | Withdrawn | Pradeesh Sivapalan | 2023-07-01 | 2023-02-23 | |
| ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study ARALAST NP - Chronic Obstructive Pulmonary Disease, Alpha1-antitrypsin Deficiency | Phase 4 | Withdrawn | Shire | 2021-03-08 | 2020-09-14 | |
| Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) In Check Dial test - Chronic Obstructive Pulmonary Disease | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2019-09-25 | 2022-08-30 | |
| To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease Aclidinium bromide/formoterol fumarate combination, Standard of Care - Chronic Obstructive Pulmonary Disease | Phase 4 | Withdrawn | AstraZeneca | 2017-12-04 | 2017-07-02 | |
| Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Erdosteine, Placebo - Chronic Obstructive Pulmonary Disease | Phase 4 | Withdrawn | Hull University Teaching Hospitals NHS Trust | 2010-08-10 | 2019-06-19 | |
| Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT) formoterol fumarate - Chronic Obstructive Pulmonary Disease, COPD | Phase 4 | Withdrawn | University of California, Los Angeles | 2008-03-01 | 2016-08-04 | |
| Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD) Inhaled Tiotropium - Chronic Obstructive Pulmonary Disease | Phase 4 | Withdrawn | NHS Greater Glasgow and Clyde | 45 | 2006-06-01 | 2010-07-28 |
Pulmonary Disease, Chronic Obstructive (7) · Bronchitis, Chronic (1) · Cough (1) · Emphysema (1) · Lung Diseases, Obstructive (1) · Smoking Cessation (1) · alpha 1-Antitrypsin Deficiency (1)
Chronic Disease (7) · Disease Attributes (7) · Lung Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Respiratory Tract Diseases (7) · Lung Diseases, Obstructive (6) · Behavior (1) · Bronchial Diseases (1) · Bronchitis (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Emphysema (1) · Genetic Diseases, Inborn (1) · Health Behavior (1)
Formoterol Fumarate (1) · Standard of Care (1) · aclidinium bromide (1) · alpha 1-Antitrypsin (1) · erdosteine (1)
AstraZeneca (1) · Hull University Teaching Hospitals NHS Trust (1) · NHS Greater Glasgow and Clyde (1) · Pradeesh Sivapalan (1) · Shire (1) · University of Alabama at Birmingham (1) · University of California, Los Angeles (1)
United Kingdom (2) · United States (2) · Denmark (1)
Alyn H Morice, FRCP (1) · Anna Ribera (1) · Anne Boyter, PhD (1) · Donald P Tashkin, M.D. (1) · Eric Kleerup, M.D. (1) · George W Chalmers, MD (1) · Jens-Ulrik S Jensen, MD, PhD (1)
PMID 11377644, PMID 15539711, PMID 15955146, PMID 16899830, PMID 18569763, PMID 19194768, PMID 19357145, PMID 19801582, PMID 20335292, PMID 20843247, PMID 21621992, PMID 23649439, PMID 24524926, PMID 24729698, PMID 25176970, PMID 25253795, PMID 26362660, PMID 26414484, PMID 26964078, PMID 27545342, PMID 29377409, PMID 31166007, PMID 32825845, PMID 34611902